CMS BALANCE Model The BALANCE Model (announced December 23, 2025) could expand GLP-1 coverage through participating Medicare Part D and Medicaid plans
Constipation is less dose-dependent and can persist, making it a more durable reason for discontinuation in patient reports. Sulfur burps reflect food sitting longer in a slowed stomach. Fatigue ranks second only to nausea in patient forums, although much of it tracks the calorie deficit rather than tirzepatide itself. Fried or fatty foods, coffee, meat, and alcohol can also become less appealing
The work of the latter authors has opened the field for further research regarding the role of L-carnitine supplementation in seizure control
Why Patients Switch: The Three Main Drivers There are three main reasons why people might switch from Ozempic to Mounjaro, or Wegovy to Zepbound: Their weight loss has stalled on their current GLP-1 Theyre experiencing intolerable side effects Their insurance coverage has changed Lets take a closer look at each of these
Once the amino acid sequence of the GLP-1 receptor was determined, the gene that codes for this protein was identified and human cells were engineered to include the gene